A Prospective Study of Higher Neural Control Changes Following Intradetrusor Injection of BotulinumtoxinA in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2018
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurogenic bladder
- Focus Therapeutic Use
- 09 Apr 2018 Status changed from active, no longer recruiting to recruiting.
- 03 Feb 2017 New trial record